Clinical investigation of medicinal products indicated for the treatment of psoriasis

  • Email
  • Help
Current effective version

Adopted guideline

Reference numberCPMP/EWP/2454/02
Published18/11/2004
Effective from01/06/2005
KeywordsPsoriasis, topical agents, corticosteroids, immunomodualtors
DescriptionThis document provides guidance for the evaluation of new medicinal products indicated for the treatment for psoriasis. It focuses mainly on the development of topical and systemic treatment of chronic plaque psoriasis.  


Related content


How helpful is this page?

Average rating:

 Based on 2 ratings

Add your rating:

See all ratings
0 ratings
0 ratings
0 ratings
1 ratings
1 ratings
    

Tell us more